MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$654,473K
(30.78%↑ Y/Y)
Other current assets
$24,246K
(-24.29%↓ Y/Y)
Other receivables
$13,585K
(-70.55%↓ Y/Y)
Prepaid data assets
$11,742K
(375.38%↑ Y/Y)
Restricted cash
$5,511K
(79.22%↑ Y/Y)
Total current assets
$709,557K
(21.47%↑ Y/Y)
Intangible assets, net
$294,073K
(-12.42%↓ Y/Y)
Goodwill
$160,170K
(1.30%↑ Y/Y)
Property and equipment,
net
$95,811K
(-24.46%↓ Y/Y)
Operating lease
right-of-use assets
$42,816K
(-19.50%↓ Y/Y)
Financing lease
right-of-use assets
$18,694K
(-24.49%↓ Y/Y)
Other assets,
non-current
$12,248K
(-17.12%↓ Y/Y)
Restricted cash,
non-current
$5,196K
(-7.69%↓ Y/Y)
Deferred tax assets
$957K
(-52.22%↓ Y/Y)
Total assets
$1,339,522K
(2.63%↑ Y/Y)
Total liabilities and
stockholders equity
$1,339,522K
(2.63%↑ Y/Y)
Total stockholders
equity
$1,024,769K
(9.72%↑ Y/Y)
Total liabilities
$314,753K
(-15.23%↓ Y/Y)
Accumulated deficit
-$2,193,506K
(-34.27%↓ Y/Y)
Additional paid-in capital
$3,191,608K
(24.99%↑ Y/Y)
Total current
liabilities
$129,699K
(-8.65%↓ Y/Y)
Unearned revenue,
non-current
$114,723K
(-11.49%↓ Y/Y)
Operating lease
liabilities, non-current
$42,842K
(-23.53%↓ Y/Y)
Deferred tax liabilities
$18,283K
(-18.51%↓ Y/Y)
Notes payable and
financing lease...
$7,181K
(-56.34%↓ Y/Y)
Other liabilities,
non-current
$2,025K
(-57.72%↓ Y/Y)
Accumulated other
comprehensive income (loss)
$26,662K
(88.49%↑ Y/Y)
Common stock, 0.00001
par value...
$5K
(25.00%↑ Y/Y)
Accrued expenses and
other liabilities
$54,205K
(-4.58%↓ Y/Y)
Unearned revenue
$32,794K
(-17.29%↓ Y/Y)
Accounts payable
$20,348K
(-18.89%↓ Y/Y)
Operating lease
liabilities
$13,087K
(10.41%↑ Y/Y)
Notes payable and
financing lease...
$9,265K
(7.90%↑ Y/Y)
Back
Back
Balance Sheet
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
source: myfinsight.com
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)